Search Results - "Shah, Shreya A"

Changes in low‐acuity patient volume in an emergency department after launching a walk‐in clinic by Kurian, Divya, Sundaram, Vandana, Naidich, Anna Graber, Shah, Shreya A., Ramberger, Daniel, Khan, Saud, Ravi, Shashank, Patel, Sunny, Ribeira, Ryan, Brown, Ian, Wagner, Alexei, Gharahbhagian, Laleh, Miller, Kate, Shen, Sam, Yiadom, Maame Yaa A. B.

“…Objective Unscheduled low‐acuity care options are on the rise and are often expected to reduce emergency department (ED) visits. We opened an ED‐staffed…”
Get full text

Ectopic intraocular lens: An unusual complication of cataract surgery by Shah, Mehul, Shah, Shreya, Aggarwal, Parul

“…We wish to report an unusual complication of intraocular lens (IOL) insertion following uneventful phacoemulsification. After successful phacoemulsification…”
Get full text

Teprotumumab-Related Adverse Events in Thyroid Eye Disease: A Multicenter Study by Shah, Shreya A, Amarikwa, Linus, Sears, Connie M, Clauss, Kevin D, Rajjoub, Raneem D, Kang, Julia Y, Tamhankar, Madhura A, Briceño, César A, Harrison, Andrew R, Dosiou, Chrysoula, Cockerham, Kimberly P, Wester, Sara T, Douglas, Raymond S, Kossler, Andrea L

“…To assess the duration, incidence, reversibility, and severity of adverse events (AEs) in patients with thyroid eye disease (TED) treated with teprotumumab…”
Get full text

CosmeticsTwitter: Predicting Public Interest in Nonsurgical Cosmetic Procedures Using Twitter Data by Cohen, Samuel A, Tijerina, Jonathan D, Shah, Shreya A, Amarikwa, Linus, Kossler, Andrea L

“…The utilization of social media in plastic surgery is expanding. The Twitter Academic Research Product Tract (TARPT) database provides plastic surgeons the…”
Get full text

Breakthrough invasive fungal infections on isavuconazole prophylaxis in hematologic malignancy & hematopoietic stem cell transplant patients by Khatri, Akshay M., Natori, Yoichiro, Anderson, Anthony, Jabr, Ra'ed, Shah, Shreya A., Natori, Akina, Chandhok, Namrata S., Komanduri, Krishna, Morris, Michele I., Camargo, Jose F., Raja, Mohammed

“…Background Isavuconazole (ISA) is a newer antifungal used in patients with history of hematologic malignancies and hematopoietic transplant and cellular…”
Get full text

Melphalan on day -1 versus day -2 in patients with plasma cell disorders undergoing autologous stem cell transplant by Watson, Aleksandra N, Shah, Shreya A, Shalhoub, Sila D, Piedra, Katrina M, Komanduri, Krishna V, Kwon, Deukwoo, Pereira, Denise L

“…High-dose melphalan-based autologous stem cell transplant (ASCT) remains a standard of care for plasma cell disorders (PCDs). Currently, there is variability…”
Get full text

A case series using famciclovir in stem cell transplant recipients with valacyclovir hypersensitivity reactions by Shah, Shreya A, Gulbis, Alison, Wilhelm, Kaci

“…Background Herpes simplex virus and varicella zoster virus reactivation can occur in up to 32% and 40% of patients, respectively in the first year…”
Get full text

Clostridium difficile infection, a descriptive analysis of solid organ transplant recipients at a single center by Tsapepas, Demetra S, Martin, Spencer T, Miao, Jennifer, Shah, Shreya A, Scheffert, Jenna, Fester, Keith, Ma, Karlene, Lat, Asma, Egan, Ron, McKeen, Jaclyn T

“…Abstract Clostridium difficile is a bacterial enteric pathogen, which causes clinical disease among solid organ transplant (SOT) recipients. This large,…”
Get full text

Reply by Shah, Shreya A., Amarikwa, Linus, Sears, Connie M., Clauss, Kevin D., Rajjoub, Raneem D., Kang, Julia Y., Tamhankar, Madhura A., Briceño, César A., Harrison, Andrew R., Cockerham, Kimberly P., Wester, Sara T., Douglas, Raymond S., Dosiou, Chrysoula, Kossler, Andrea L.

Get full text

Teprotumumab-Related Adverse Events in Thyroid Eye Disease by Shah, Shreya A., Amarikwa, Linus, Sears, Connie M., Clauss, Kevin D., Rajjoub, Raneem D., Kang, Julia Y., Tamhankar, Madhura A., Briceño, César A., Harrison, Andrew R., Dosiou, Chrysoula, Cockerham, Kimberly P., Wester, Sara T., Douglas, Raymond S., Kossler, Andrea L.

“…To assess the duration, incidence, reversibility, and severity of adverse events (AEs) in patients with thyroid eye disease (TED) treated with teprotumumab…”
Get full text

Incidence of Laboratory Tumor Lysis Syndrome in CAR T-Cell Recipients by Sicre, David, Shah, Shreya A, Shalhoub, Sila D, Piedra, Katrina M, Spiegel, Jay

“…Tumor lysis syndrome (TLS) is a complication commonly seen in hematological malignancies after patients receive antineoplastics due to the rapid release of…”
Get full text

Reply by Shah, Shreya A, Amarikwa, Linus, Sears, Connie M, Clauss, Kevin D, Rajjoub, Raneem D, Kang, Julia Y, Tamhankar, Madhura A, Briceño, César A, Harrison, Andrew R, Cockerham, Kimberly P, Wester, Sara T, Douglas, Raymond S, Dosiou, Chrysoula, Kossler, Andrea L

Get full text

Reply by Shah, Shreya A, Amarikwa, Linus, Sears, Connie M, Clauss, Kevin D, Rajjoub, Raneem D, Kang, Julia Y, Tamhankar, Madhura A, Briceño, César A, Harrison, Andrew R, Cockerham, Kimberly P, Wester, Sara T, Douglas, Raymond S, Dosiou, Chrysoula, Kossler, Andrea L

Get full text

A Retrospective Series of Vedolizumab Use for Steroid Refractory Acute Graft-Versus-Host Disease by Shah, Shreya A, Wang, Trent P, Shalhoub, Sila D, Taylor, Breanna J, Piedra, Katrina M, Pereira, Denise, Komanduri, Krishna V., Lekakis, Lazaros J., Goodman, Mark, Jimenez, Antonio, Beitinjaneh, Amer

Get full text

Safety of the Recombinant Herpes-Zoster Subunit Vaccine in Allogeneic Stem Cell Transplant Patients by Shalhoub, Sila D, Shah, Shreya A., Camargo, Jose F., Komanduri, Krishna V., Wang, Trent P

“…After allogeneic stem cell transplant (SCT), varicella zoster virus (VZV) necessitates long term chemoprophylaxis due to limitations of the live vaccine. The…”
Get full text

Busulfan Pharmacokinetics Using 25% Adjusted Body Weight in Obese Stem Cell Transplant Patients by Shalhoub, Sila D, Taylor, Breanna J, Piedra, Katrina M, Beitinjaneh, Amer, Shah, Shreya A

“…The use of adjusted body weight for dosing of conditioning chemotherapy is recommended in obese stem cell transplant (SCT) patients. Busulfan (Bu),…”
Get full text